Cell-free culture supernatant of Bifidobacterium breve CNCM I-4035 decreases pro-inflammatory cytokines in human dendritic cells challenged with Salmonella typhi through TLR activation
about
Proteinaceous Molecules Mediating Bifidobacterium-Host InteractionsThe role of probiotic lactic acid bacteria and bifidobacteria in the prevention and treatment of inflammatory bowel disease and other related diseases: a systematic review of randomized human clinical trialsDetermining antioxidant activities of lactobacilli cell-free supernatants by cellular antioxidant assay: a comparison with traditional methodsEffects of Lactobacillus paracasei CNCM I-4034, Bifidobacterium breve CNCM I-4035 and Lactobacillus rhamnosus CNCM I-4036 on hepatic steatosis in Zucker rats.Modulation of immunity and inflammatory gene expression in the gut, in inflammatory diseases of the gut and in the liver by probiotics.Probiotic Bifidobacterium species stimulate human SLC26A3 gene function and expression in intestinal epithelial cells.Safety and immunomodulatory effects of three probiotic strains isolated from the feces of breast-fed infants in healthy adults: SETOPROB study.Probiotic actions on diseases: implications for therapeutic treatments.Gut ecosystem: how microbes help us.Lactobacillus amylovorus inhibits the TLR4 inflammatory signaling triggered by enterotoxigenic Escherichia coli via modulation of the negative regulators and involvement of TLR2 in intestinal Caco-2 cells and pig explantsPyrosequencing analysis reveals changes in intestinal microbiota of healthy adults who received a daily dose of immunomodulatory probiotic strains.Oral administration of Bifidobacterium breve B-3 modifies metabolic functions in adults with obese tendencies in a randomised controlled trial.Preferential production of G-CSF by a protein-like Lactobacillus rhamnosus GR-1 secretory factor through activating TLR2-dependent signaling events without activation of JNKs.Age-related changes in gut microbiota composition from newborn to centenarian: a cross-sectional study.Role of intestinal microbiota and metabolites on gut homeostasis and human diseases.Use of Lactobacillus plantarum Strains as a Bio-Control Strategy against Food-Borne Pathogenic MicroorganismsIntravenous Administration Is an Effective and Safe Route for Cancer Gene Therapy Using the Bifidobacterium-Mediated Recombinant HSV-1 Thymidine Kinase and Ganciclovir.Evidence of the Anti-Inflammatory Effects of Probiotics and Synbiotics in Intestinal Chronic Diseases.Influences of environmental bacteria and their metabolites on allergies, asthma, and host microbiota.Probiotic Modulation of Innate Cell Pathogen Sensing and Signaling Events.Lactobacillus rhamnosus protects human colonic muscle from pathogen lipopolysaccharide-induced damage.A Metagenomic and in Silico Functional Prediction of Gut Microbiota Profiles May Concur in Discovering New Cystic Fibrosis Patient-Targeted Probiotics.Probiotic strains and mechanistic insights for the treatment of type 2 diabetes.Antiproliferative Effects of Bacillus coagulans Unique IS2 in Colon Cancer Cells.Immune-Mediated Mechanisms of Action of Probiotics and Synbiotics in Treating Pediatric Intestinal Diseases.A Salmonella Typhi ghost induced by the E gene of phage φX174 stimulates dendritic cells and efficiently activates the adaptive immune response.Lactobacillus rhamnosus and its cell-free culture supernatant differentially modulate inflammatory biomarkers in Escherichia coli-challenged human dendritic cells.
P2860
Q26740603-A05F2191-D53C-488F-AE8D-A81B98163404Q27001546-CC9DF8C8-51B0-4517-8EDE-11600AEFAD89Q28544714-2DA1F91D-E3C4-44C2-BA21-413DE5F665AFQ33650508-C2FC1068-3FD9-4CF0-9693-C7DE7E39E0DCQ34499067-D378DFC7-8A6F-4F09-A3A0-09F00CFDBD69Q34726615-006CA6D6-7660-448A-83DF-84886D194749Q35036054-4838FFE4-E985-4EF4-9A35-265A7DEFBE79Q35096915-EB0BAC90-3EAC-4A07-848A-89F916E9FA17Q35105266-484C0341-4C03-4E02-B8E2-E5131AD50A84Q35148077-D512389A-6115-4805-A11B-94680B2DB6B2Q35643130-FFD1D171-86B3-43C9-90D6-9E320AC43DCCQ35718362-DD49F199-C482-48C5-8718-787784E68E1CQ35821701-D6F92793-6EF2-467D-896E-7E71BED2B9AFQ36028377-79A3F874-47F1-4924-9381-2DD080F92B67Q36243299-8A747AEC-08D5-4185-AFD8-5A98DC3FE8C9Q36792496-605FAA15-6296-48CE-AD53-D058FCA2E4E8Q37050672-696A39F9-6346-4A3E-9F91-82D8F8F25E30Q39336917-08A618D4-C315-4186-A34F-265A67D6AD07Q39363751-84FA97CC-B175-4FFE-8DD0-FA5E309A4228Q43691887-02BBD645-2F61-456F-BD73-B5D903088DC0Q45795481-477E4520-D97D-454D-BF9D-1C4963E4F852Q46242881-C0A655D3-5B40-4861-A4E2-03D19D6FF725Q46279792-7051D9F8-DCCA-4C90-9172-4E495C8CCD3EQ47803305-F255055A-5C75-4422-826C-15BC969E2CCDQ49433372-3AA01E9C-E4C8-4D75-961A-78E68A9B2C2CQ52591488-C6BCD63E-BD65-43EE-9384-7CEAB90118D2Q54295984-F1A3CF7F-C14A-40D6-A006-3F2CCC37EB18
P2860
Cell-free culture supernatant of Bifidobacterium breve CNCM I-4035 decreases pro-inflammatory cytokines in human dendritic cells challenged with Salmonella typhi through TLR activation
description
2013 nî lūn-bûn
@nan
2013 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մարտին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
name
Cell-free culture supernatant ...... a typhi through TLR activation
@ast
Cell-free culture supernatant ...... a typhi through TLR activation
@en
Cell-free culture supernatant ...... a typhi through TLR activation
@nl
type
label
Cell-free culture supernatant ...... a typhi through TLR activation
@ast
Cell-free culture supernatant ...... a typhi through TLR activation
@en
Cell-free culture supernatant ...... a typhi through TLR activation
@nl
prefLabel
Cell-free culture supernatant ...... a typhi through TLR activation
@ast
Cell-free culture supernatant ...... a typhi through TLR activation
@en
Cell-free culture supernatant ...... a typhi through TLR activation
@nl
P2093
P2860
P50
P1433
P1476
Cell-free culture supernatant ...... a typhi through TLR activation
@en
P2093
Esther Matencio
Fernando Romero
Maria J Bernal
Sergio Muñoz-Quezada
P2860
P304
P356
10.1371/JOURNAL.PONE.0059370
P407
P577
2013-03-12T00:00:00Z